neximmune.com (NEXI) - Company Cash Volume

Official company branding of NexImmune, Inc. (NEXI)

NexImmune, Inc. (NEXI) develops AIM AI systems for T-cell stimulation while adhering to strict FDA regulations regarding biomaterial utilization. Management's key priority remains the advancement of personalized immunotherapy through clinical trials. The GURU.Markets portal features a chart of the organization's cash balance dynamics, where the current value is recorded at 0.00, confirming the issuer's current liquidity position.

NEXI - NexImmune Corp Company Cash Reserve over the range 07/04/2022 - 08/04/2024

Analytical breakdowns for NexImmune, Inc.

- current price and projected stock value:
Fundamental company valuation:NexImmune Inc NEXI
Brand item of NexImmune

This indicator determines the volume of liquid funds available for operational management and the generation of interest income. By analyzing the company's cash assets, an investor assesses the issuer's ability to maintain financial stability without external borrowing. The metric captures the balance between savings deposits and current expenses. For NexImmune, Inc. (NEXI), this reserve is critical for the uninterrupted maintenance of laboratories. Stable R&D funding allows elite immunologists to focus on developing cancer cell therapy.

Competitors of NexImmune, Inc. (NEXI)

Company Cash on Hand IBRX (ImmunityBio Corp)|Company Total Cash Amount IMCR|Company Cash Volume JANX (Janux Therapeutics, Inc.)|Company Cash Balance RCUS|zymeworks.com - Company Cash Volume|Company Cash Reserve Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Company Cash Funds|Immatics N.V. - Company Cash Balance|XNCR (xencor.com) - Company Cash Volume|Company Cash Volume Compass Therapeutics Inc|Company Cash Funds Replimune (REPL)|LYEL: Company Total Cash Volume|Innate Pharma SA - Company Cash on Hand|Pyxis Oncology, Inc. (PYXS) - Company Cash Reserve|Compugen - Company Cash Volume|Company Liquid Assets IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Company Cash on Hand|INKT - Company Liquid Assets|Company Cash Funds werewolftx.com|Company Cash on Hand Immix Biopharma, Inc. (IMMX)|Company Cash on Hand ALXO (ALX Oncology Holdings)|Company Cash Funds CUE (Cue Biopharma)|Company Cash Volume PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Company Cash Reserve|MAIA Biotechnology - Company Cash Volume|LIMN - Company Cash Volume|LVTX: Company Cash Volume|NextCure - Company Cash Balance|LPTX (Leap Therapeutics Inc) - Company Cash Volume|INTS (Intensity Therapeutics, Inc.) - Company Total Cash Amount|Company Cash Volume SNSE|Company Cash Funds TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Company Cash on Hand|Company Cash Volume Kineta KA|turnstonebio.com - Company Cash Volume|VCNX (Vaccinex, Inc) - Company Cash and Cash Equivalents|Harpoon Therapeutics (HARP) - Company Cash Funds